Equities
Leclanché Files Insolvency for Two German Subsidiaries Amid Liquidity Crisis
Battery maker files precautionary insolvency proceedings for German units in Offenburg as funding remains unsecured; shares suspended from trading.
Roche Aktie fällt nach EU-Zulassung für Susvimo
Schweizer Pharmakonzern erhält grünes Licht für Augenmedikament in EU, doch Aktie reagiert mit Kursverlust
Novo Nordisk faces investor skepticism over pipeline diversification strategy
CEO Doustdar outlines plans to expand beyond diabetes and obesity but warns of patent cliff risks ahead of 2030
NBPE Reports H1 2024 Earnings: Portfolio Returns and Buybacks Drive Gains
Net Asset Value (NAV) rose 1.9% in dollars and 3.4% in sterling, with buybacks and private equity portfolio performance key drivers.
Definium’s DT120 Shows Strong Phase III Results for GAD, MDD
Data from two GAD trials and one MDD study suggest efficacy without adjunctive therapy, with potential for FDA breakthrough designation.
Fortinet shares hit all-time high of $176.23 after earnings beat and AI acquisition
Fortinet stock rose to $176.23, its highest level, as revenue jumped 26% to $2.05 bn and the company announced the purchase of AI security firm Virtue AI. Analysts lifted price targets, with TD Cowen seeing $215.
Pool Corp stock drops 47% to $165.21, hits 52-week low
Company reports Q2 2026 earnings but misses revenue expectations as analysts cut price targets amid broader market decline
Hub Group Stock Touched 52-Week Low as Nasdaq Compliance Risks Mount
Shares of the transportation and logistics firm fell to $31.37, down nearly 24% year-to-date, while accounting delays raise the prospect of a Nasdaq delisting.
Lemonade Shares Fall to 52‑Week Low of $46.12 Despite Q2 Revenue Beat
The insurtech’s stock touched its lowest level in a year after reporting second‑quarter 2026 revenue that beat estimates, while adjusted EBITDA loss narrowed and free cash flow remained positive.
Solidium reduces stake in Sampo to 3.55%, below 5% threshold
State-owned investor Solidium Oy cut its holding in Finnish insurer Sampo plc to 3.55% of shares and voting rights, down from just under 10% previously disclosed.
Helus Pharma’s HLP-003 Shows Promise in Phase III MDD Trial
The company’s deuterated psilocin candidate aims to advance to FDA filing by 2028, with early efficacy data supporting its adjunctive use in depression treatment.
Alkami Board Reaffirms Independence, Full-Year Financial Guidance
The Dallas-based fintech company said its board unanimously concluded remaining independent best serves shareholders, while reaffirming FY revenue guidance of $528M–$531M and adjusted EBITDA of $96M–$98M.
ARK ETFs trade biotech stocks, sell Tempus AI, buy Scribe Therapeutics
On Sept. 23, 2026 ARK's thematic ETFs sold about $7 million of Tempus AI shares and added roughly $6 million of Scribe Therapeutics, Beam Therapeutics, Veracyte and other positions.
Aurora’s 2026 Investor Day: Driverless Trucks Scale on Dallas-Houston Route
Aurora Innovation Inc. showcased its autonomous trucking progress, including commercial deployments and fleet expansion plans, at its 2026 Analyst Day.
US Stocks Set for Weaker Open as Oil Reverses Slide
Futures point to a lower start for Wall Street as Brent and WTI recover from recent declines, while geopolitical risks from US-Iran and US-China talks linger.
US Futures Slip; Oil Bounces, SMI Erases Gains, Nvidia Pre-Market Down
Wall Street opens lower as oil stabilizes and geopolitical hopes offset by chip-sector pullback; SMI surrenders morning gains ahead of SNB decision.
AppLovin Stock Falls 3.5% Amid Edgewater Research Warning on Growth Stagnation
AppLovin’s shares declined 3.5% after analyst Joe Wittine from Edgewater Research downgraded the mobile ad platform’s outlook, citing slowed market share growth and intensifying competition.
E-Power Subsidiary Collects $9.2M for Battery Anode Design Phase
E-Power Inc.'s Chinese unit received a $9.2M payment, representing roughly 18% of a $51.2M turnkey contract for lithium-ion battery anode production lines.
XTEND Secures Phase III Contract for Special Operations Drones
XTEND announced it has been awarded a Phase III contract to supply special operations drones.
IM Cannabis Raises $1.31 Million in Registered Direct Offering
The medical cannabis company issued 655,000 common shares at $2.00 each, raising proceeds for working capital as it prepares to sell its German operations.
Aurora Cannabis files complaint over Curaleaf takeover bid
Aurora Cannabis has filed a complaint regarding Curaleaf's takeover bid, according to Investing.com.
Jayden Resources Closes Oversubscribed C$1M Private Placement
Vancouver-based mining firm raised C$1,030,614 by selling over 5.28 million units at C$0.195 each, exceeding its initial C$1 million target.
Stitch Fix Q4 2026 slides show transformation progress, FY27 concerns
Finance Review Daily is tracking this developing story; no further verified information could be confirmed at this time.
Abacus Founders Cancel Rule 10b5-1 Stock Sale Plans, Retain Shares
The three founders of Abacus Global Management terminated their pre‑arranged trading plans and decided to keep their current stakes in the NYSE‑listed firm. The move comes as they step back from day‑to‑day operations while remaining among the company’s largest shareholders.